These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6512346

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Su-polysaccharide skin test and immunotherapy with OK-432 in postoperative gastric cancer--the effect of a splenectomy].
    Saito H, Kikkawa H, Bando H, Sakatoku M, Hirano M, Tatsuzawa T.
    Gan No Rinsho; 1988 Nov; 34(14):1965-8. PubMed ID: 3204664
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunological parameters in gastric cancer patients treated with immunotherapy of streptococcal preparation OK-432.
    Hanaue H, Nomoto S, Kimura T, Kutsuna T, Takeuchi T, Yoshizaki S.
    Keio J Med; 1982 Dec; 31(4):159-68. PubMed ID: 6985379
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of immunochemotherapy with streptococcal preparation "OK-432" on inoperable advanced cancers (author's transl)].
    Nio Y, Nitta N, Tanaka A, Ichikawa T, Henmi K.
    Nihon Geka Hokan; 1981 Sep 01; 50(5):704-10. PubMed ID: 7332399
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of endoscopical administration of OK-432 in 4 patients with advanced esophageal or gastric cancer].
    Satomi T, Inoue S, Fujita T, Ogawa S, Honda H, Hayashi M.
    Gan No Rinsho; 1989 Mar 01; 35(4):512-5. PubMed ID: 2541269
    [Abstract] [Full Text] [Related]

  • 11. [Studies of immunotherapy of malignant urogenital tumors: 2nd report. Changes in the K-cell population of the peripheral blood in patients with malignant tumors and the significance of antibody dependent cell-mediated cytotoxicity (ADCC) in OK-432 immunotherapy].
    Fujioka T, Tanji S, Koike H, Suzuki K, Aoki H, Banya Y, Kubo T, Ohhori T.
    Nihon Hinyokika Gakkai Zasshi; 1987 Jan 01; 78(1):29-38. PubMed ID: 3599595
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Postoperative cell-mediated immunity in gastric cancer patients--with special reference to the effects of immunotherapy].
    Sekizuka H, Noro K, Haruyama S, Kiribuchi Y, Hayashi F.
    Gan No Rinsho; 1985 Sep 01; 31(11):1381-6. PubMed ID: 3877822
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T, Nio Y, Imai S, Tsubono M, Morimoto H, Tseng CC, Tobe T, Tanaka T, Kitamura O, Sakanashi S.
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr 20; 25(4):799-811. PubMed ID: 2196311
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer].
    Yamane T, Sagara Y, Suzuki G, Kasuga M, Sakita M, Fujita Y, Majima S.
    Gan To Kagaku Ryoho; 1984 Apr 20; 11(4):930-4. PubMed ID: 6721507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.